Merck & Co., Inc.

MRK · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$17$0$15$12
Dep. & Amort.$4$4$4$3
Deferred Tax-$1-$2-$2$0
Stock-Based Comp.$1$1$1$0
Change in WC-$4-$2-$3-$4
Other Non-Cash$4$12$4$2
Operating Cash Flow$21$13$19$14
Investing Activities
PP&E Inv.-$3-$4-$4-$4
Net Acquisitions-$4-$12-$0-$13
Inv. Purchases-$1-$1-$1-$0
Inv. Sales/Matur.$0$2$1$1
Other Inv. Act.-$0$1$0-$0
Investing Cash Flow-$8-$14-$5-$17
Financing Activities
Debt Repay.$2$4-$2$2
Stock Issued$0$0$0$0
Stock Repurch.-$1-$1$0-$1
Dividends Paid-$8-$7-$7-$7
Other Fin. Act.-$0-$0-$0$8
Financing Cash Flow-$7-$5-$9$3
Forex Effect-$0$0-$0-$0
Net Chg. in Cash$6-$6$5$0
Supplemental Information
Beg. Cash$7$13$8$8
End Cash$13$7$13$8
Free Cash Flow$18$9$15$10